山东大学耳鼻喉眼学报 ›› 2019, Vol. 33 ›› Issue (4): 10-17.doi: 10.6040/j.issn.1673-3770.1.2019.027
摘要:
下咽癌发生位置隐蔽,早期症状不明显,超过2/3的下咽癌临床上初诊时为中晚期,是头颈肿瘤中预后较差的一种恶性肿瘤。近年来,倡导手术、放疗与化疗相结合的综合治疗模式以改善预后。诱导化疗在器官保留以及减少远处转移上的治疗价值日渐受到重视。但在实际临床工作中,主管医师对指南和各治疗手段利弊的理解以及临床经验的差异,诱导化疗在局部晚期下咽癌治疗中的作用仍存在争议。如何根据患者的全身和局部情况在众多的治疗方法中选择最合理的治疗手段是下咽癌治疗过程中一直在探讨的问题。通过文献回顾和个案剖析讨论诱导化疗在局部晚期下咽癌治疗中的作用。
中图分类号:
1 | 屠规益, 胡郁化. 下咽癌的外科治疗[J]. 中华耳鼻咽喉科杂志, 1986, 12: 85- 87. |
2 |
张宗敏, 唐平章, 徐震纲, 等. 下咽鳞癌不同治疗方案的临床分析[J]. 中华肿瘤杂志, 2005, 27 (1): 48- 51.
doi: 10.3760/j.issn:0253-3766.2005.01.013 |
ZHANG Zongmin , TANG Pingzhang , XU Zhengang , et al. Long-term results of different treatment modalities in 464 hypopharyngeal squamous-cell carcinoma patients[J]. Chin J Oncol, 2005, 27 (1): 48- 51.
doi: 10.3760/j.issn:0253-3766.2005.01.013 |
|
3 |
Ma J , Liu Y , Huang XL , et al. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: A meta-analysis[J]. Oral Oncol, 2012, 48 (11): 1076- 1084.
doi: 10.1016/j.oraloncology.2012.06.014 |
4 |
Bauman J , Langer C , Quon H , et al. Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck[J]. Experimental and Therapeutic Medicine, 2013, 5 (4): 1247- 1253.
doi: 10.3892/etm.2013.948 |
5 |
Janoray G , Pointreau Y , Garaud P , et al. Long-term results of a multicenter randomized phase Ⅲ trial of induction chemotherapy with cisplatin, 5-fluorouracil, ±docetaxel for larynx preservation[J]. J Natl Cancer Inst, 2016, 108 (4): djv368.
doi: 10.1093/jnci/djv368 |
6 |
廖恺, 毕卓菲, 何艳, 等. TPF或PF方案诱导化疗治疗局部晚期头颈鳞癌的Meta分析[J]. 循证医学, 2012, 12 (5): 278- 285.
doi: 10.3969/j.issn.1671-5144.2012.05.007 |
LIAO Kai , BI Zhuofei , HE Yan , et al. Induction chemotherapy with cisplatin and fluorouracil alone or with taxanes for locally advanced squamous-cell cancer of the head and neck: A meta-analysis[J]. J Evid-Based Med, 2012, 12 (5): 278- 285.
doi: 10.3969/j.issn.1671-5144.2012.05.007 |
|
7 |
Pointreau Y , Garaud P , Chapet S , et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation[J]. Journal of the National Cancer Institute, 2009, 101 (7): 498- 506.
doi: 10.1021/jf011209e |
8 |
Fabregas JC , Loaiza-Bonilla A , Talebi TN , et al. Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer[J]. Expert Rev Anticancer Ther, 2013, 13 (9): 1065- 1072.
doi: 10.1586/14737140.2013.829639 |
9 |
Voichita BA , Joshua P , Yang HS , et al. Current management of locally advanced head and neck cancer : the combination of chemotherapy with locoregional treatments[J]. Seminars in Oncology, 2014, 41 (6): 798- 806.
doi: 10.1053/j.seminoncol.2014.09.018 |
10 |
Cohen EE , Karrison TG , Kocherginsky M , et al. Phase Ⅲ randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer[J]. J Clin Oncol, 2014, 32 (25): 2735- 2743.
doi: 10.1200/JCO.2013.54.6309 |
11 |
Lefebvre JL . Laryngeal preservation in head and neck cancer: multidisciplinary approach[J]. Lancet Oncol, 2006, 7 (9): 747- 755.
doi: 10.1016/S1470-2045(06)70860-9 |
12 |
Tada Y , Maruya SI , Saotome T , et al. Phase Ⅰ/Ⅱ study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma[J]. Oncol Lett, 2012, 4 (5): 898- 904.
doi: 10.3892/ol.2012.846 |
13 |
鲁光平, 潘骥群, 刘志标. DCF方案诱导化疗后手术治疗喉癌及下咽癌T2-3病变疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29 (7): 585- 588.
doi: 10.13201/j.issn.1001-1781.2015.07.002 |
LU Guangping , PAN Jiqun , LIU Zhibiao . Efficacy analysis of sequential surgery after the DCF scheme induction chemotherapy in T2-3 laryngeal carcinoma and hypopharyngeal carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29 (7): 585- 588.
doi: 10.13201/j.issn.1001-1781.2015.07.002 |
|
14 |
Denaro N , Russi EG , Lefebvre JL , et al. A systematic review of current and emerging approaches in the field of larynx preservation[J]. Radiother Oncol, 2014, 110 (1): 16- 24.
doi: 10.1016/j.radonc.2013.08.016 |
[1] | 黄泽雷,宋琦,路秀英,崔兰珍,李晓明. 双氢青蒿素对下咽癌Fadu细胞内质网应激途径的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 31-35. |
[2] | 黄河,欧阳晖. 下咽癌共病食管癌的高危因素及预后分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 82-86. |
[3] | 黄志刚. CO2激光手术治疗咽喉部肿瘤[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 1-3. |
[4] | 代亚错,李靖,万保罗,臧艳姿,黄颖铭. 个体化治疗咽喉部海绵状血管瘤二例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 110-112. |
[5] | 李文明,魏东敏,孙睿杰,钱晔,刘大昱,解光,雷大鹏,潘新良. 下咽癌侵犯颈段食管的治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 15-19. |
[6] | 董频,英信江,陈歆维,邓志宏,张少强,於子卫,金斌,孙臻峰,谢晋,祝江才. 新辅助化疗方案尼妥珠单抗联合奈达铂和5-氟尿嘧啶治疗下咽鳞癌初步临床分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 10-14. |
[7] | 李晓明,宋琦,李红霞,陶振峰,申宇鹏,肖淑芬. 胸大肌肌皮瓣在侵犯下咽晚期头颈鳞癌手术切除术后缺损修复中的应用[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 4-9. |
[8] | 胡文良,郑艳秋,崔晓波,崔彦茹,孙源昊. 下咽癌中差异表达的蛋白激酶及其抑制剂的生物信息学筛选[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 24-28. |
[9] | 江昌,许承弼,辛丁,鞠洋,李鸿燕,王金月. 下咽癌腋窝淋巴结转移1例及文献回顾[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 90-92. |
[10] | 李嘉, 黎雄文, 张鹏坚, 叶远航, 秦勇. 个体化减张整形术与传统黏膜下切除术治疗鼻中隔偏曲的比较研究[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 31-34. |
[11] | 郑立友. 中西医结合治疗喉癌下咽癌手术并发咽瘘10例[J]. 山东大学耳鼻喉眼学报, 2012, 26(6): 31-33. |
[12] | 沈斌,董频,英信江,高尚,李大伟. ABCG2及NF-κB p65在下咽癌中的表达意义[J]. 山东大学耳鼻喉眼学报, 2012, 26(4): 17-20. |
[13] | 曹汉海1,丁海霞2,彭洪娟3. 多层螺旋CT后处理技术对下咽癌评估的价值[J]. 山东大学耳鼻喉眼学报, 2011, 25(3): 25-27. |
[14] | 叶婷1,马超2,潘新良1. 下咽癌瘤内淋巴管生成及颈淋巴转移关系的研究[J]. 山东大学耳鼻喉眼学报, 2011, 25(1): 24-. |
[15] | 曾志梅1,梁永辉2,杨嶷芳2, 窦晓清2, 罗碧强2,张丽卫2,陈贤明2. 巨噬细胞移动抑制因子在下咽癌中的表达[J]. 山东大学耳鼻喉眼学报, 2011, 25(1): 17-19. |
|